Results 231 to 240 of about 62,107 (256)
Some of the next articles are maybe not open access.
Human medicines European public assessment report (EPAR): Amgevita, adalimumab, Arthritis, Psoriatic,Colitis, Ulcerative,Arthritis, Juvenile Rheumatoid,Spondylitis, Ankylosing,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 21/03/2017, Revision: 6, Status: Authorised
Case Medical Research, 2019 openaire +2 more sourcesHuman medicines European public assessment report (EPAR): Inflectra, infliximab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Colitis, Ulcerative,Psoriasis,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 09/09/2013, Revision: 23, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Amsparity, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Colitis, Ulcerative,Crohn Disease,Hidradenitis Suppurativa, Date of authorisation: 13/02/2020, Status: Authorised
Case Medical Research, 2020 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Halimatoz, adalimumab, Hidradenitis Suppurativa,Psoriasis,Arthritis, Juvenile Rheumatoid,Uveitis,Arthritis, Rheumatoid,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 26/07/2018, Revision: 4, Status: Authorised
Case Medical Research, 2019 openaire +1 more source
